Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

NCT05410509

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Thomas Jefferson Health Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL

NCT04168788

Conditions
Acute Lymphoblastic Leukemia, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +30 more
Locations
  • Univesity Hostipal of Amiens Amiens, France
  • University Hospital of Bordeaux Bordeaux, France
  • University of Brest Brest, France
  • Centre Oscar Lambret Lille, France
View Trial Details
Completed

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

NCT00942331

Conditions
Advanced Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +32 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
View all 873 locations
View Trial Details
Completed

A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

NCT04919512

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Urological Associates of Southern Arizona, P.C. Tucson, Arizona, United States
  • UAMS Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • Arkansas Urology Little Rock, Arkansas, United States
View all 109 locations
View Trial Details
Completed

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

NCT00326898

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
View all 987 locations
View Trial Details

Related conditions